Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.04) per share from the same period last
According to Benzinga Pro data, during Q2, Marrone Bio Innovations (NASDAQ:MBII) posted sales of $12.60 million. Earnings were up 12.38%, but Marrone Bio Innovations still reported an overall loss of $2.53 million.